Clinical Trial Update: Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing long-term safety of MOA-728 in participants with opioid-induced constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MOA-728

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-10-18